Merck & Co., Inc. (MRK) Stock, AZN Stock
narvikk/E+ via Getty Images
Against a backdrop of rising geopolitical tensions between the United States and China, there are signs of growing negotiating activity between Western pharmaceutical companies and Chinese biotechs, several research firms suggest.
Big pharma companies have licensed almost a third of their external molecules of Chinese origin.